MABSA is pleased to announce our upcoming 35th Annual Hybrid Biosafety Symposium. Please register and pay at www.mabsa.org.
DATE: Thursday, June 15, 2023 **In-person registration deadline is 05/31/2023.**
LOCATION: Merck & Company, Inc. (Rahway, NJ)
AGENDA
8:10am – 8:30 am — ABSA update
- Lou Ann Burnett, MS, CBSP(ABSA), Past President of ABSA
8:30 am – 9:20 am — “Lessons from a Vial” – Bio-Inventories: Compliance or Catastrophe
- Eric Lewis, PhD, Merck Senior Specialist, Safety and Environment, West Point, PA
- Greg Moyer, RBP, Associate Director, Global Safety and Environment
9:20 am – 10:10 am — Application of Biosafety Protocols for the Study of Cancer
- Ana M. Gamero, PhD, Associate Professor, Medical Genetics and Molecular Biochemistry, Associate Professor, Fels Cancer Institute for Personalized Medicine, Associate Professor, Cancer and Cellular Biology
10:30 am – 12:30 pm — Roundtable: The Biosafety Professionals
- Andrew B. Maksymowych, PhD, RBP(ABSA). Institutional BSO, Associate Director for Life Sciences Safety & Compliance Programs, IBC Administrator, ARO, ICDUR, EHRS, University of Pennsylvania
- Paul Meechan, PhD, MPH, RBP(ABSA), CBSP(ABSA), SM(NRCM). Biorisk consultant
- Lou Ann Burnett, MS, CBSP(ABSA), Past President of ABSA
1:30 pm – 2:20 pm — Laboratory Acquired Infection reports in the literature that resulted in changes in laboratory practice within the laboratory
- Karen Byers, MS, RBP(ABSA), CBSP(ABSA), Biosafety Officer, Dana-Farber Cancer Institute
2:40 pm – 3:30 pm — CDC inspections, a retrospective
- Sean Fitzgerald, MPH, RBP(ABSA), Manager of Biological Safety and Environmental Health and Safety, The Center for Discovery and Innovation (CDI)
REGISTRATION: Please register and pay at www.mabsa.org
- Member Registration: $50.00 in person/$25.00 virtual
- Non-Member Registration: $70.00 in person/$45 virtual — Non-member registration offers one year membership in 2023.
- Student Registration: $20.00 in person/$10.00 virtual
